• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Human Source Severe Acute Respiratory Syndrome Coronavirus 2 Aerosol Transmission to Remote Sentinel Hamsters

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2025 Apr 1;12(4):ofaf196.
doi: 10.1093/ofid/ofaf196. eCollection 2025 Apr. Human Source Severe Acute Respiratory Syndrome Coronavirus 2 Aerosol Transmission to Remote Sentinel Hamsters

Chad J Roy[SUP] 1 [/SUP], Michael R Barer[SUP] 2 3 [/SUP], Veronica Ueckermann[SUP] 4 [/SUP], Brandon Beddingfield[SUP] 1 [/SUP], David Cordier[SUP] 4 [/SUP], Bernard Fourie[SUP] 4 [/SUP], Richard Vincent[SUP] 5 [/SUP], Sego Dibobo[SUP] 4 [/SUP], Toby VanReenen[SUP] 4 [/SUP], Paul Jensen[SUP] 6 [/SUP], Oliva De Kock[SUP] 7 [/SUP], Elsabe De Kock[SUP] 7 [/SUP], Edward Nardell[SUP] 8 [/SUP]



Affiliations
Abstract

Background: Bioaerosol-mediated transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via building ventilation systems has yet to be convincingly demonstrated. We used the South African Airborne Infections Research (AIR) facility near Pretoria to study human-to-animal (H2A) transmission of SARS-CoV-2 in newly diagnosed patients. While the facility was built to study tuberculosis transmission, this was its first adaptation to study H2A virus transmission.
Methods: Patients with clinically confirmed coronavirus disease 2019 were housed for up to 4 days in in the AIR facility with continuously exhausting patient ward air to hamsters housed in animal exposure rooms. After a 3-week exposure period, animals were held for an additional week to allow for antibody development. Animal sera were analyzed for anti-spike and plaque reduction activities and lung samples for pathology.
Results: Seven patients provided ≥400 in-residence hours over a 17-day period. Pair-housed naive golden Syrian hamsters (n = 216) received continuous exposure to mixed patient ward exhaust. Serum analyses revealed anti-SARS-CoV-2 immunoglobulin G in 58% of animals tested. Plaque reduction assays on 7 high-titer serum samples revealed neutralizing activity.
Conclusions: These results support the concept that viral bioaerosols generated from patients remain infectious over long-distance transport through a building ventilation system. The seroconversion among sentinel animals supports the long-held belief that airborne infections manifest as a stochastic rather than deterministic event that is subject to a threshold dose effect. Further confirmatory studies are necessary to characterize the relationship between the bioaerosol delivered and the infections that result in this controlled H2A transmission model.

Keywords: COVID-19; hamster; infectious aerosols; infectious disease aerobiology; respiratory transmission.

 
Back
Top Bottom